利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

32 条记录 (耗时 0.037 秒)

    Rate control during AF using cellular intervention to modulate AV node
    3.
    发明申请
    Rate control during AF using cellular intervention to modulate AV node 有权
    使用细胞干预调整AV节点的AF期间的速率控制

    公开(公告)号：US20060247697A1

    公开(公告)日：2006-11-02

    申请号：US11116621

    申请日：2005-04-28

    申请人： Vinod Sharma ,  Daniel Sigg

    发明人： Vinod Sharma ,  Daniel Sigg

    IPC分类号： A61N1/362

    CPC分类号： A61N1/362 ,  A61K9/0019 ,  A61K31/221 ,  A61K38/177 ,  A61N1/0568

    摘要： A biologic intervention method and apparatus generates a persistent modification to an AV node that is physiologically stable after the agent has matured but is alterable with subsequent application of an agent. Specifically, the generic agent is used to modulate a node in a cardiac conduction system including rate control using one and a combination of a family of K+ channel or equivalent. Specifically, the channel is implemented to slow conduction by generating an outward current during optimization of action potential and repolarization phase thus decreasing the current that is available to excite downstream cells. A Kv 1.3 channel, for example, may be used as the biologic channel. The invention enables reversal of the modulation or adjustment for various heart rates (BPM) based on medical and patient-specific needs.

    摘要翻译： 生物干预方法和装置对于在该药剂已经成熟但随后随后施用药剂而可变化的生理稳定的AV节点产生持久性修饰。 具体地，通用试剂用于调制心脏传导系统中的节点，包括使用一个和一组K + SUPER通道或等同物的组合的速率控制。 具体地，通过在动作电位和复极相优化期间产生向外的电流来实现缓慢传导，从而减少可用于激发下游单元的电流。 例如，可以使用Kv1.3通道作为生物通道。 本发明能够根据医疗和患者特定的需要逆转各种心率（BPM）的调节或调整。

    Universal actuator particularly for dashboards
    5.
    发明申请
    Universal actuator particularly for dashboards 有权
    通用执行器特别适用于仪表盘

    公开(公告)号：US20070189025A1

    公开(公告)日：2007-08-16

    申请号：US10569084

    申请日：2004-08-27

    申请人： Daniel Sigg ,  Corinne Zuppiger-Lachat

    发明人： Daniel Sigg ,  Corinne Zuppiger-Lachat

    IPC分类号： B60Q1/124

    CPC分类号： G01D11/28

    摘要： An electric dashboard actuator including an electric motor driving an indicator. The electric motor includes a hollow output shaft of which the ends are located at and flush with two opposite surfaces of the motor, and the indicator includes a male coupling member with a cross-section matching the cross-section of the hollow motor output shaft. One motor surface includes a male or female coupling perpendicular to the surface.

    摘要翻译： 包括驱动指示器的电动马达的电气仪表板执行器。 电动机包括中空输出轴，其端部位于并与电动机的两个相对表面齐平，并且该指示器包括具有与中空电动机输出轴的横截面匹配的横截面的阳联接构件。 一个电动机表面包括垂直于表面的阳或阴耦合。

    Delivery of a sympatholytic cardiovascular agent to the central nervous system
    6.
    发明申请
    Delivery of a sympatholytic cardiovascular agent to the central nervous system 有权
    交配性心血管药物向中枢神经系统递送

    公开(公告)号：US20050177097A1

    公开(公告)日：2005-08-11

    申请号：US10903599

    申请日：2004-07-30

    申请人： Keith Hildebrand ,  Michael Ujhelyi ,  Xiaohong Zhou ,  Daniel Sigg ,  Linda Page

    发明人： Keith Hildebrand ,  Michael Ujhelyi ,  Xiaohong Zhou ,  Daniel Sigg ,  Linda Page

    IPC分类号： A61B5/02 ,  A61M5/142 ,  A61M5/168 ,  A61M5/172 ,  A61N1/39 ,  A61K31/137 ,  A61K9/22 ,  A61K31/24

    CPC分类号： A61M5/142 ,  A61M5/14276 ,  A61M5/1723 ,  A61M2005/14208 ,  A61M2205/3523 ,  A61M2230/00 ,  A61M2230/04 ,  A61M2230/63 ,  A61N1/3962

    摘要： A sympatholytic cardiovascular agent delivered by a drug delivery pump to a central nervous system site to alleviate symptoms of acute or chronic cardiac insult or impaired cardiac performance. The drug delivery pump can be external or implantable infusion pump (IIP) coupled with a drug infusion catheter extending to the site. A patient activator can command delivery of a dosage and/or an implantable heart monitor (IHM) coupled with a sensor can detect physiologic parameters associated with cardiac insult or impaired cardiac performance and trigger dosage delivery. The IIP and IHM can be combined into a single implantable medical device (IMD) or can constitute separate IMDs that communicate by any of known communication mechanisms. The sympatholytic cardiovascular agent is one of the group consisting of an alpha-adrenergic agonist and an alpha2-adrenergic agonist (e.g., clonidine, p-aminoclonidine, guanabenz, lidamidine, tizanidine, moxonidine, methyldopa, xylazine, guanfacine, detomidine, medetomidine, and dexmedetomidine).

    摘要翻译： 由药物输送泵递送至中枢神经系统部位的交感神经心血管药物以缓解急性或慢性心脏损伤或心脏功能受损的症状。 药物输送泵可以是外部或植入式输液泵（IIP），其与延伸到现场的药物输注导管结合。 患者活化剂可以命令递送剂量和/或与传感器耦合的可植入心脏监测器（IHM）可以检测与心脏损伤相关的生理参数或心脏功能受损并触发剂量递送。 IIP和IHM可以组合成单个可植入医疗设备（IMD），或者可以构成通过任何已知的通信机制进行通信的单独IMD。 交感神经心血管药剂是由α-肾上腺素能激动剂和α2-肾上腺素能激动剂（例如可乐定，对氨基可乐定，胍苯胺，利脒，替扎尼定，莫索尼定，甲基多巴，甲苯噻嗪，胍法西林，美托洛尼，美托咪定和 右美托咪定）。

    Dashboard indicator module
    8.
    发明授权
    Dashboard indicator module 有权
    仪表板指示灯模块

    公开(公告)号：US08347807B2

    公开(公告)日：2013-01-08

    申请号：US12301706

    申请日：2007-05-23

    申请人： Daniel Sigg ,  Corinne Zuppigger-Lachat

    发明人： Daniel Sigg ,  Corinne Zuppigger-Lachat

    IPC分类号： G01D11/28

    CPC分类号： G01D11/28 ,  B60K2350/1064 ,  G01D13/265

    摘要： A dashboard indicator module including a rotating actuator including a hollow output shaft controlling movement of an indicator with a light conducting path, connected to a light source, diffusing a light at an angle, and a reduction gear set. The external diameter of the conducting path is between 2.6 and 5.5 millimeters.

    摘要翻译： 一种仪表板指示器模块，包括旋转致动器，其包括中空输出轴，其控制指示器与导光路径的移动，连接到光源，以一角度散射光和减速齿轮组。 导电路径的外径为2.6至5.5毫米。

    SYSTEM AND METHOD FOR DELIVERY OF BIOLOGIC AGENTS
    10.
    发明申请
    SYSTEM AND METHOD FOR DELIVERY OF BIOLOGIC AGENTS 审中-公开
    用于递送生物代理的系统和方法

    公开(公告)号：US20100114057A1

    公开(公告)日：2010-05-06

    申请号：US12262866

    申请日：2008-10-31

    申请人： Prasanga Hiniduma-Lokuge ,  Daniel Sigg

    发明人： Prasanga Hiniduma-Lokuge ,  Daniel Sigg

    IPC分类号： A61J1/14

    CPC分类号： A61M5/286 ,  A61M5/282 ,  A61M5/284 ,  A61M25/0068 ,  A61M25/0082

    摘要： A container for housing a therapeutic agent includes a body member, a sealing element, and a rupturable membrane. The body member has a proximal end and a distal end and a lumen that extends from the proximal end to the distal end. The sealing element is slidably disposable in the lumen. The sealing element is configured to sealingly engage the body member as the element is slid within the lumen. The rupturable membrane is disposed across the lumen in proximity to the distal end of the body member.

    摘要翻译： 用于容纳治疗剂的容器包括主体构件，密封元件和可破裂膜。 主体构件具有近端和远端以及从近端延伸到远端的内腔。 密封元件在内腔中可滑动地一次性使用。 密封元件构造成当元件在管腔内滑动时密封地接合主体构件。 可破裂膜跨过内腔设置在主体构件的远端附近。